logo-loader
viewVolitionRx

VolitionRx to ring Wall St Closing Bell Monday

VolitionRx Limited's senior management team will ring the closing bell at the New York Stock Exchange (NYSE) 1600 EDT

NYSEBell_181756628.jpg
The closing bell

Some market events can be positively fun and exciting.

That’s the case for VolitionRx Limited (NYSEMKT:VNRX) which confirmed on Monday that members of its senior management team and Board of Directors, including Chief Executive Officer, Cameron Reynolds, will ring the closing bell at the New York Stock Exchange (NYSE) 1600 EDT.

This event recognises the Company's recent announcement of a CE mark for its Nu.QTM Colorectal Cancer Screening Triage Test from the European Union, the company said.

Only last Friday the company updated on its 2016 achievements.

Read: VolitionRx looks forward to another year of continued success

It was also good to learn that the stock was 1.3% higher on Wall Street at $4.55 on Monday.

Quick facts: VolitionRx

Price: 4.58 USD

NYSEMKT:VNRX
Market: NYSEMKT
Market Cap: $188.2 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

VolitionRx CEO discusses 'spectacular' results from Nu.Q proof of concept study

VolitionRx Limited's (NYSEAMERICAN:VNRX) Cameron Reynolds discusses with Proactive London's Andrew Scott the results from the latest proof of concept study on its Nu.Q cancer-test assay. He says the finding's have revealed an impressive ability to detect with accuracy non-Hodgkins lymphoma...

1 week, 2 days ago

2 min read